The "SURF1 Gene Leigh Syndrome due to COX Deficiency Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE, aimed at detecting mutations in the SURF1 gene. These mutations are known to cause Leigh Syndrome, a severe neurological disorder that typically emerges in the first year of life. Leigh Syndrome associated with cytochrome c oxidase (COX) deficiency is specifically linked to the SURF1 gene alterations. This condition leads to progressive loss of mental and movement abilities, which can be fatal. The test, which costs 3200 AED, is crucial for early diagnosis and management of the syndrome. It involves analyzing the patient's DNA to identify any mutations in the SURF1 gene, providing vital information for treatment planning and genetic counseling for affected families. Conducted in the advanced facilities of DNA Labs UAE, this test is a key step towards personalized medicine for patients with Leigh Syndrome due to COX deficiency.
The MT-ND5 gene Leigh syndrome due to mitochondrial complex I deficiency is a genetic condition that affects the nervous system and other bodily functions. This condition is caused by mutations in the MT-ND5 gene, which is part of the mitochondrial DNA. These mutations lead to a deficiency in mitochondrial complex I, a crucial component of the mitochondrial respiratory chain responsible for energy production in cells. Symptoms of Leigh syndrome can include developmental delay, muscle weakness, breathing difficulties, and neurological problems.
To diagnose this specific form of Leigh syndrome, a genetic test is available at DNA Labs UAE. This test specifically looks for mutations in the MT-ND5 gene to confirm a diagnosis of Leigh syndrome due to mitochondrial complex I deficiency. The test is crucial for accurate diagnosis and management of the condition, allowing for tailored treatment plans and genetic counseling for affected families.
The cost of the MT-ND5 gene Leigh syndrome genetic test at DNA Labs UAE is 4400 AED. This investment covers the process of collecting a DNA sample, usually through a blood draw or cheek swab, and the detailed analysis conducted in the laboratory to detect any mutations in the MT-ND5 gene. Given the complexity of the test and the specialized technology used, the cost reflects the extensive resources required for accurate diagnosis.
For families and individuals facing symptoms indicative of Leigh syndrome, this genetic test provides a vital tool for understanding the underlying genetic cause and opens the door to targeted interventions and support services.
The "NDUFA12 Gene Leigh Syndrome due to Mitochondrial Complex I Deficiency Genetic Test" is a specialized diagnostic tool designed to identify mutations in the NDUFA12 gene, which are associated with Leigh syndrome. This condition is a severe neurological disorder that typically emerges in the first year of life, characterized by progressive loss of mental and movement abilities. Leigh syndrome is often linked to mitochondrial complex I deficiency, a critical issue in cellular energy production.
The test is carried out by DNA Labs UAE, a leading facility in genetic diagnostics, ensuring high accuracy and reliability. By analyzing the patient's DNA, the test can pinpoint specific genetic alterations in the NDUFA12 gene, confirming a diagnosis of Leigh syndrome due to mitochondrial complex I deficiency. This information is crucial for understanding the disease's progression, potential interventions, and family planning considerations.
The cost of the test is set at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify the genetic markers associated with this condition. By opting for this test, patients and their families can gain valuable insights into the genetic underpinnings of Leigh syndrome, facilitating informed decisions regarding management and treatment strategies.
The LIPT1 gene is associated with a rare genetic condition known as Leigh syndrome, specifically linked to deficiencies in the pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase complexes. These complexes play critical roles in cellular energy production through the mitochondrial oxidative phosphorylation pathway. Mutations in the LIPT1 gene can disrupt these processes, leading to a spectrum of clinical manifestations including neurological and muscular impairments, among others.
To diagnose this specific form of Leigh syndrome, genetic testing for LIPT1-related mutations is essential. DNA Labs UAE offers a comprehensive genetic test aimed at identifying mutations in the LIPT1 gene. This test is crucial for confirming the diagnosis, understanding the disease's progression, and potentially guiding treatment options.
The cost of the LIPT1 gene Leigh syndrome genetic test at DNA Labs UAE is 4400 AED. This investment includes the process of collecting a DNA sample, usually through a blood draw or cheek swab, and analyzing the genetic material for specific mutations in the LIPT1 gene. The result from this test can provide invaluable information for affected individuals and their families, including genetic counseling and the possibility of participating in targeted therapies or clinical trials.
The TACO1 gene Leigh syndrome due to the mitochondrial complex IV deficiency genetic test is a specialized diagnostic tool designed to identify mutations in the TACO1 gene, which are associated with Leigh syndrome, a severe neurological disorder. This condition is characterized by mitochondrial complex IV deficiency, leading to a range of symptoms such as psychomotor regression, hypotonia, and respiratory abnormalities. The test is crucial for early diagnosis and management of the syndrome, providing essential information for personalized treatment plans.
Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities, the test offers a comprehensive analysis of the TACO1 gene to detect any mutations that could be responsible for the condition. With a cost of 4400 AED, it represents a significant investment in the health and well-being of individuals at risk of or suspected to have Leigh syndrome. Early detection through this genetic test can be pivotal in managing the syndrome's progression and improving the quality of life for affected individuals.
The LRPPRC gene Leigh syndrome French-Canadian type genetic test is a specialized diagnostic tool designed to identify mutations in the LRPPRC gene, which are responsible for causing Leigh syndrome French-Canadian type, a rare and severe neurological disorder. This genetic condition is particularly noted for its prevalence among the French-Canadian population of Quebec, but it can occur in other populations as well. Leigh syndrome is characterized by progressive loss of mental and movement abilities, leading to severe physical and neurological disabilities.
The test involves analyzing the patient's DNA to detect specific mutations in the LRPPRC gene, which play a crucial role in cellular energy production. Identifying these mutations can confirm a diagnosis of Leigh syndrome French-Canadian type, enabling early intervention and management of the condition.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the test offers a comprehensive analysis with a focus on accuracy and reliability. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to perform this detailed genetic analysis. Early diagnosis through this test can significantly impact the management of the syndrome, allowing for tailored treatments and supportive care to improve the quality of life for affected individuals and their families.
The HPRT1 gene Lesch-Nyhan syndrome genetic test is a specialized diagnostic tool aimed at identifying mutations in the HPRT1 gene, which are responsible for causing Lesch-Nyhan syndrome. This rare, inherited disorder is characterized by overproduction of uric acid in the body, leading to kidney and bladder stones, and neurological and behavioral abnormalities, including self-mutilating behaviors. The test is crucial for early diagnosis, enabling appropriate management and treatment plans to be established for affected individuals.
Conducted at DNA Labs UAE, a leading facility in genetic testing, this test provides a comprehensive analysis of the HPRT1 gene to detect any abnormalities or mutations. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then meticulously analyzed in the laboratory using advanced genetic sequencing technologies.
The cost of the HPRT1 gene Lesch-Nyhan syndrome genetic test is 4400 AED. Although the price may seem high, the value of obtaining an accurate diagnosis cannot be overstated, as it opens the door to targeted treatment options and genetic counseling for families affected by this condition. Given the complexity and the specialized nature of this test, it is conducted by highly trained professionals who ensure the accuracy and confidentiality of the results.
The AIMP1 Gene Leukodystrophy Hypomyelinating Type 3 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the AIMP1 gene, which are associated with Hypomyelinating Leukodystrophy Type 3. This condition is a rare genetic disorder characterized by the abnormal development of the white matter in the brain, leading to a range of neurological symptoms and challenges. The test, priced at 4400 AED, involves the analysis of the patient's DNA to detect specific genetic alterations in the AIMP1 gene, providing crucial information for accurate diagnosis, prognosis, and the potential for personalized treatment strategies. DNA Labs UAE employs state-of-the-art genetic testing technologies to ensure reliable and precise results, supporting patients and their families in understanding and managing this complex condition.
The HSPD1 Gene Leukodystrophy Hypomyelinating Type 4 Genetic Test is a specialized diagnostic tool designed to identify mutations in the HSPD1 gene, which are associated with Hypomyelinating Leukodystrophy Type 4. This condition is a rare genetic disorder characterized by the insufficient formation of myelin, the protective sheath around nerve cells in the brain, leading to neurological problems. The test is crucial for confirming the diagnosis, understanding the disease progression, and guiding treatment decisions.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves analyzing the patient's DNA to look for specific mutations in the HSPD1 gene that are known to cause the disorder. The process is meticulous and requires a sample of the patient's blood or saliva.
The cost of the test is set at 4400 AED, reflecting the comprehensive analysis and the specialized technology employed to detect the mutations accurately. Getting tested at DNA Labs UAE ensures that patients and their families receive reliable results, thanks to the lab's commitment to high standards of testing and its use of cutting-edge genetic technologies. This test is an essential step for families seeking answers to complex genetic disorders, offering them a path towards better management and understanding of Hypomyelinating Leukodystrophy Type 4.
The FAM126A gene leukodystrophy, hypomyelinating type 5, is a rare genetic disorder characterized by the abnormal development of white matter in the brain, leading to a range of neurological symptoms such as motor dysfunction, muscle stiffness, and developmental delays. The condition is caused by mutations in the FAM126A gene, which plays a crucial role in the formation and maintenance of myelin, the protective sheath surrounding nerve fibers.
To diagnose this condition, a genetic test can be conducted to identify mutations in the FAM126A gene. DNA Labs UAE offers a specialized genetic testing service for this purpose. The test is designed to provide a definitive diagnosis by analyzing the patient's DNA for specific mutations associated with hypomyelinating leukodystrophy type 5. This can be particularly useful for confirming the diagnosis in patients exhibiting symptoms of the disorder, as well as for carrier testing in family members of affected individuals.
The cost of the FAM126A gene leukodystrophy hypomyelinating type 5 genetic test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect the presence of FAM126A gene mutations. Upon completion, the results can offer valuable insights into the patient's condition, guiding treatment decisions and management strategies to improve quality of life.
